Kriti Nutrients shareholders approve ₹3.00 dividend, reappoint board
- Shareholders approved ₹3.00 interim dividend per share for FY26, totaling ₹1,503.11 lakh
- Promoter group held 33,410,469 shares, voting on nearly 100% of holdings
- Shiv Singh Mehta reappointed as CMD for three years; Saurabh Singh Mehta as JMD
- Statutory auditors M/s M Mehta & Co reappointed for second five-year term
- Public shareholder participation rate was just 0.32% despite high promoter engagement

*this image is generated using AI for illustrative purposes only.
Kriti Nutrients shareholders approved an interim dividend of ₹3.00 per equity share for FY26 and reappointed key directors at the 30th Annual General Meeting held on August 12, 2026.
The meeting, conducted via video conferencing from Indore, saw all eight resolutions passed with requisite majorities. The promoter group held 33,410,469 shares as on the cut-off date of August 5, 2026, representing approximately 66.7% of the total outstanding equity.
Key Resolutions Passed
Shareholders approved the adoption of audited standalone and consolidated financial statements for the year ended March 31, 2026. The Board confirmed the interim dividend payout aggregating ₹1,503.11 lakh on 5,01,03,520 equity shares of face value ₹1 each.
Director Appointments and Remuneration
The AGM focused heavily on leadership continuity and compensation structures:
- Mr. Saurabh Singh Mehta was reappointed as a Director liable to retire by rotation. Shareholders also approved a revision in his remuneration as Whole-Time Director and Joint Managing Director, effective April 1, 2026, to July 31, 2027.
- Mr. Shiv Singh Mehta, Chairman and Managing Director, was reappointed for a three-year term from January 12, 2027, to January 11, 2030.
- Both directors received approval for aggregate annual remuneration exceeding 5% of net profits, calculated under Section 198 of the Companies Act, 2013.
Audit and Compliance
Members ratified the remuneration of Cost Auditors M/s Dhananjay V. Joshi & Associates at ₹35,000 plus taxes for FY27. Statutory Auditors M/s M Mehta & Company were reappointed for a second consecutive five-year term until the conclusion of the 35th AGM in 2031.
What the Numbers Show
The voting data reveals a distinct divergence in shareholder engagement between promoter and public categories. While the promoter group cast votes on nearly 100% of their holdings (33,408,469 votes polled against 33,410,469 held), non-institutional public shareholders participated minimally, polling only 52,943 votes against 16,677,388 shares held—a participation rate of just 0.32%. This indicates that governance decisions are overwhelmingly driven by promoter voting power rather than broad retail engagement.
| Resolution Type | Votes In Favour | Votes Against | Approval Rate |
|---|---|---|---|
| Financial Statements | 33,461,410 | 2 | 100.00% |
| Interim Dividend | 33,461,410 | 2 | 100.00% |
| Director Remuneration (S. S. Mehta) | 33,460,546 | 866 | 99.99% |
| CMD Reappointment (S. S. Mehta) | 33,461,410 | 2 | 100.00% |
The minimal opposition—only two votes against financial approvals and 866 against remuneration revisions—underscores strong promoter control over corporate governance outcomes.
Historical Stock Returns for Kriti Nutrients
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.11% | -5.31% | -8.89% | +26.13% | -13.71% | 0.0% |
How will the revised remuneration structure for the Joint Managing Director impact Kriti Nutrients' net profit margins and operational efficiency in FY27?
Given the extremely low retail shareholder participation rate of 0.32%, what strategies might management implement to improve minority investor engagement in future governance decisions?
Will the continuation of high promoter voting power influence future capital allocation decisions, such as potential buybacks or additional equity raises?


































